Treatment Modalities of Muscle Invasive Transitional Cell Carcinoma of Bladder

Authors

  • ATM Mowladad Chowdhury Professor of Urology, Department of Urology, BIRDEM and Ibrahim Medical College, Dhaka, Bangladesh
  • Bakhtiar Ahmed Registrar, Department of Urology, BIRDEM and Ibrahim Medical College, Dhaka, Bangladesh
  • Md Muntasir Chowdhury Resident Medical Officer, Department of Urology, BIRDEM and Ibrahim Medical College, Dhaka, Bangladesh

DOI:

https://doi.org/10.3329/bju.v23i2.50316

Keywords:

muscle invasive bladder, MIBC, NAC

Abstract

The treatment of muscle invasive bladder cancer (MIBC) is complex. This review describes the available therapies for invasive urothelial carcinoma. Neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) and lymph node dissection has been considered the slandered treatment for MIBC. Many patients those are unfit for surgery or cisplatin ineligible, bladder sparing strategies are considered in highly selected patients. Even though there are no level I data, the treatment outcomes for highly select patients given bladder sparing therapy appear promising, with many patients retaining a functional bladder. So it can be concluded that treatment of MIBC is a multidisciplinary collaborative program of surgery, radiation and medical oncology.

Bangladesh Journal of Urology, Vol. 23, No. 2, July 2020 p.205-209

Downloads

Download data is not yet available.
Abstract
20
PDF
45

Downloads

Published

2020-11-15

How to Cite

Chowdhury, A. M., Ahmed, B., & Chowdhury, M. M. (2020). Treatment Modalities of Muscle Invasive Transitional Cell Carcinoma of Bladder. Bangladesh Journal of Urology, 23(2), 205–209. https://doi.org/10.3329/bju.v23i2.50316

Issue

Vol. 23 No. 2 (2020)

Section

Review Articles